Gov. Ron DeSantis delayed Florida's special session on redistricting to April 28, expanding the agenda to include AI and ...
Gov. Ron DeSantis delayed Wednesday a long-anticipated special session to redraw the state’s congressional maps, pushing it ...
LONDON, April 1 (Reuters) - Vaccine makers Pfizer (PFE.N), opens new tab and BioNTech (22UAy.DE), opens new tab halted a large U.S. trial of their updated COVID-19 vaccine in healthy adults aged 50 to ...
Traveler Carlos Avila, arriving from Barbados, swabs his nose to test for COVID variants and other contagious viruses as part of a nationwide effort to track new and emerging infectious diseases, on ...
An unnamed global tech company will pay $15 million to settle a federal investigation into its COVID-19 vaccine mandate. The EEOC found "reasonable cause" that the company discriminated against ...
WASHINGTON — Service members forced to leave the military for refusing to take the COVID-19 vaccine now have an extra year to return to the service, if they so choose, Secretary of War Pete Hegseth ...
Prefer Newsweek on Google to see more of our trusted coverage when you search. Neal Browning, one of the first people to test the COVID-19 Moderna mRNA vaccine, has taken to social media six years ...
The Advisory Committee on Immunization Practices’ COVID-19 Immunization Workgroup has proposed three federal actions to address post-acute COVID-19 vaccination syndrome, or PACVS, a condition ...
Add Yahoo as a preferred source to see more of our stories on Google. The US Centers for Disease Control and Prevention's vaccine advisory committee is scheduled to meet again next week. - Elijah ...
A group of experts that advises the US Centers for Disease Control and Prevention on its vaccine recommendations has suspended an anticipated push to stop recommending mRNA-based Covid-19 vaccines ...
BioNTech's stock fell 19% after its co-founders said they are leaving to start a new mRNA-based company Ugur Sahin and Özlem Türeci, the co-founders of BioNTech, were given the Axel Springer Award in ...
Moderna said it settled patent lawsuits over its blockbuster COVID-19 vaccine for $950 million, with another $1.3 billion payout possible depending on the outcome of a federal appeal. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results